title: [Design, synthesis and characterization of cyanopyrrolidine-bearing compounds as DPP-4 inhibitors].
abstract: OBJECTIVE
  To synthesize novel cyanopyrrolidine-bearing compounds as dipeptidyl peptidase 4 (DPP4) inhibitors and characterize their biological activities in vitro.
  
  
  METHODS
  Eleven analogues of carbonitrilpyrrolidine were designed and synthesized by substitution reaction of (S)-2-(2-cyanopyrrolidin-1-yl)acetyl bromide with substituted phenyl piperazine pyridazinones.
  
  
  RESULTS
  The structures of the compounds were characterized by (1)H-NMR and MS spectra. Biological evaluation indicated that most of the compounds exhibited moderate inhibitory activities against DPP4.
  
  
  CONCLUSIONS
  The preliminary bioassay indicates that all the synthesized compounds have moderate DPP-4 inhibition activity, especially the compounds 1j and 1k with inhibition rates reaching 26.14% and 34.15% at the concentration of 1×10(5) nmol/L, respectively.
authors.affiliation: College of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. wenlingwang8503@163.com
authors.forename: Wenling
authors.initials: W
authors.lastname: Wang
authors.forename: Huixian
authors.initials: H
authors.lastname: Jiang
authors.forename: Jianxin
authors.initials: J
authors.lastname: Pang
authors.forename: Zhihong
authors.initials: Z
authors.lastname: Jiang
authors.forename: Baomin
authors.initials: B
authors.lastname: Xi
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry*; D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000138:chemical synthesis* / Q000737:chemistry; D011759:Pyrrolidines / Q000737:chemistry*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D011759:Pyrrolidines; C032519:pyrrolidine